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Abstract
The Shiga toxins comprise a family of related protein toxins secreted by
certain types of bacteria. Shigella dysenteriae, some strain of Escherichia
coli and other bacterias can express toxins which caused serious compli-
cation during the infection. Shiga toxin and the closely related Shiga-
like toxins represent a group of very similar cytotoxins that may play
an important role in diarrheal disease and hemolytic-uremic syndrome.
The outbreaks caused by this toxin raised serious public health crisis and
caused economic losses. These toxins have the same biologic activities and
according to recent studies also share the same binding receptor, globotrio-
syl ceramide (Gb3). Rapid detection of food contamination is therefore
relevant for the containment of food-borne pathogens. The conventional
methods to detect pathogens, such as microbiological and biochemical
identification are time-consuming and laborious. The immunological or
nucleic acid-based techniques require extensive sample preparation and
are not amenable to miniaturization for on-site detection. In the present
are necessary of techniques of rapid identification, simple and sensitive
which can be employed in the countryside with minimally-sophisticated
instrumentation. Biosensors have shown tremendous promise to overcome
these limitations and are being aggressively studied to provide rapid, re-
liable and sensitive detection platforms for such applications.
——————————————————————————————
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1 Introduction
1.1 Preliminaries
Shiga toxin was isolated from Shigella dysenteriae serotype 1 by Kiyoshi Shiga
in 1898, which named it Bacillus dysenterie [1]. In his work, Shiga described
the production of the toxic factors actually known as Shiga toxin [2]. Shiga
toxin-producing Escherichia coli (STEC) was discovered in 1977, and it was
associated with the clinical hemolytic-uremic syndrome (HUS) in 1983, a life-
threatening condition characterized by hemolytic anemia, thrombocytopenia,
and renal failure [3]. This toxin has been also associated with hemorrhagic colitis
and other severe disease conditions. Most of the work in the identification and
characterization of Shiga toxin has been focused on E. coli O157:H7 strains,
although many cases of Shiga toxin associated disease were caused by other
serotypes of E. coli [1].
The main reservoirs of STEC are cattle and sheep, but other animals are
recognized as a risk factor such as: deer, dogs, birds and horses. Nevertheless,
new vehicles of infection resulting from environmental contamination and the
intensive farming are continuously been identified [4]. Shiga toxin-producing
Escherichia coli may cause diarrhea, bloody diarrhea and hemorrhagic colitis.
The transmission of STEC may occurs through contaminated foods, such as
ground beef, through contaminated water and by person-to-person interaction
[5]. Fecal-oral transmission is also a common mode of transmission. Other
ways to acquire that disease is the direct contact with animals on farms or
at zoos. The leafy greens and unpasteurized apple cider are other recognized
exposure sources. The transmission from person-to-person can occur directly
(households, child care centers, institutions) or indirectly (contaminated drink-
ing or recreational water) [6]. The ingestion of undercooked hamburgers in
fast-food restaurants, was associate with the production of hemorrhagic colitis
(HC), produced by STEC [7]. Stool cultures from patients infected in these
episode, yielded a previously rarely isolated E. coli serotype, O157:H7. It has
been reported that many E. coli strains isolated from these inpatients with diar-
rheal illness produce a Shiga-like toxin (SLT), including one of the strains that
produce the Vero cytotoxin [8]. Afterward O’Brien et al., showed that Shiga-like
toxin and the Vero cytotoxin were the same toxin [9]. Bacterial infections caused
by Shiga toxin are responsible of many disease and the death of a great number
of people. These infections have become a growing threat to the human health
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with worse manifestations in developed countries where the bacterias able to
release Shiga-like toxins has been found in different food, including milk, apple
juice and vegetables.
Surveillance data from the Center for Disease Control (CDC) of the U.S. for
the 1998 calendar year showed an increase in the number of confirmed outbreaks
of E. coli O157:H7 infection, from an average of 31 per year between 1994 and
1997 to 42 in 1998. In most of the Asian countries, STEC is not yet a major
health problem, except in Japan, where 29 outbreaks were reported between
1991 to 1995 [9]. The first documentation of outbreak was produced by an
episode involving strain O157:H7, in 1982 causing hemorrhagic colitis. Since
then, the incidence of this strain in the diseases has increased annually [10].
An important massive outbreak of O157:H7 that gained particular attention
happened in the western U.S. in 1993, having 501 cases, 151 hospitalizations
and 45 cases of HUS. This outbreak was linked to consumption of undercooked
hamburger meat at a fast food restaurants [11]. More recently, the transmission
of foodborne bacteria remains an important public health threat because of
the increased consumption of fresh vegetables and fruits, and the increased
consumption of foods in public restaurants. The 80 % of cases of bacterial
diarrhea that occurs every year in the United States are a result of foodborne
transmission. Shiga toxin–producing E. coli is among the four most commonly
reported bacterial enteropathogens and contributes to an estimated cost of $7
billion annually. STEC in particular, causes approximately 100,000 illnesses,
3,000 hospitalizations and 90 deaths annually in the United States [12].
Numerous outbreaks, as well as sporadic cases of STEC infections and HUS,
have been documented worldwide. The largest outbreaks were recorded in in-
dustrialized countries. The modern industrialized large-scale food production
might serve as a widespread vector in cases of food contamination. In Ger-
many, STEC were commonly recognized as pathogens causing rare but severe
disease almost exclusively in younger children. Before 2011, about 1,000 STEC
infections per year and fewer than 100 cases of HUS were registered. The 2011
outbreak of a STEC O104:H4 in Northern Germany started at the beginning of
May, reaching its peak on May 22. This an unusual outbreak of diarrhea with
HUS affected Germany and was spread to other European countries, United
States and Canada. Until July 4, when the end of the outbreak was officially
declared 4075 cases: 3935 in Germany, with 48 dead, while in set of the other
countries affected during this outbreak, were reported 140 cases [13].
The most comparable historical outbreak to the recent German epidemic,
was took place in Japan in 1996 (Sakai city outbreak). About 6,000 persons were
affected after white radish sprouts had been served at school canteens, exposing
47,000 children to the contaminated food. The incidence of HUS in the Sakai
city outbreak was considerably lower (106 cases out of 6,000 infections). Another
outbreak of a STEC O157:H7 have occurred in 1996, in Scotland, involving 512
persons, of whom 279 cases were microbiologically confirmed. One of the largest
non-O157 STEC outbreaks was caused in Oklahoma in 2008, which reported 341
cases with gastroenteritis, 71 patients required hospitalization and 1 patient died
[14].
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The virulence of E. coli 0157:H7 can partially be attributed to its ability to
establish infection at low doses in humans. The majority of STEC infections
present with hemorrhagic colitis as 91% of patients give a history of bloody
diarrhea at some point during their illness. Significant morbidity and mortality
secondary to infection is attributed to the development of HUS [12]. Among the
E. coli O157:H7 has received the most attention by the scientific and regulatory
community because of its association with several large outbreaks of human
illness with severe manifestations [15]. Even when the growing knowledge about
toxins and its interaction with cells have allowed the production of molecules
that help to treat this type of infection [16], this help some times comes out
of time, as most of the above infections where confirmed several days after the
initial episode.
It is known that available methods are not characterized by its speed. How-
ever, it is our intuition that biochemically-driven toxin detection can improve
the speed of diagnosis kits for bacterial diseases. Currently, no extensive re-
search on Stx identification and quantification is available. The purpose of this
work is to review the state-of-the art techniques for Stx detection, trying to
describe all the biological and (bio)chemical approaches for its diagnostics.
2 The Shiga family of toxins
2.1 Structural Characteristics
Shiga Toxin and Shiga-like Toxin belong to large family of plants and bacterial
toxins. The real Shiga Toxin (Stx) is produced by Shigella dysenteriae and is
almost identical to Shiga-like toxin 1 (Stx1). Shiga-like toxin is secreted by some
strains of Escherichia coli (STEC), and also Citrobacter freundii, Aeromonas
hidrofilas, Aeromonas caviae y Enterobacter cloacae have been reported able to
express the toxin. Although the Shiga-like toxin is have a similar structure, do
not have the same effect on cells [17] .
As said before, the virulence factor of Shiga toxin, also known as verotoxin,
causes hemorrhagic colitis and diarrhea and in the most severe cases leads to
the lethal hemolytic-uremic syndrome. The primary virulence factor in systemic
host responses produced by clinical isolates of STEC is Shiga toxin type 2 (Stx2),
but some isolates produce both Stx1 and Stx2, or more rarely only Stx1 [18].
The two serological types of verotoxin, Stx1 and Stx2, are formed by a active
enzymatic complex with a subunit A and five subunit B (Figure 1) [19]. The
fragment A has an internal disulfide bond which when processed proteolytically
generates two subunit: A1 and A2. The A1 fragment inhibits protein synthesis
after it is released in the cytosol by the elimination of one adenine from the 28S
RNA of the 60S ribosomal subunit [20]. The B pentamer, of 89 aminoacids, can
join the terminal of disaccharide galabiose (gal-α1,4-gal) in the surface of the
host cells. This interaction carbohydrate-toxin can be used to STEC detection
[21].
The molecular weight of the toxin is around 70kD, composed by subunit A of
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Figure 1: 3-D structure of Shiga toxin A and B subunits . (Taken from RCSB
Protein Data Bank)
32 kD and each subunit B of 7.7 kD. Stx1 is virtually identical to Stx, differing
in only one aminoacid residue, whereas the Stx2 isoforms share less sequence
similarity with Stx (60%). Toxins Stx1 and Stx2 have similar structure but
differ in their sequences (Figure 2): the fragment A has 315 aminoacid, while for
Stx2 the subunit A show 318 aminoacid [16]. Although their primary sequence
of aminoacid are related, Stx1 and Stx2 are immunologically different: both
are able to join the Gb3 receptor but they do not target same organs and
tissues[22]. Gb3 is expressed in many cells of the body human, but the fact
that amongst the more common complication hemorragic colitis and the HUS
are prevalent, suggests that the infection is directed to specific organs. For
example, Gb3 is expressed in the kidneys, mainly in the pediatric glomeruli,
and when the kidneys becomes adult this expression decreases or is lost. This
fact explains why HUS observed in children is mainly caused by Stx1 [23]. It
has been reported that 90% of HUS cases occurs in children younger than three
years old. Furthermore has been observed that Stx1 binds little or nothing in
adults renal glomeruli[24].
The affinity of Stx1 by the receptor Gb3 is ten times bigger than with Stx2.
The Shiga toxin genes are located in the bacteriophage (bacteria virus), which
is associated with all pathogenic STEC [25]. The Stx1 and Stx2 are secreted by
different ways and are translated in different ways across the outer membrane
[26].
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Figure 2: 3-D structures of Stx1(A) and Stx2 (B), showing its differences.
(Taken from RCSB Protein Data Bank)
In eukaryotic cells the surface receptor for members of the Stx family is
the neutral glycosphingolipid globotriaosylceramide (Gb3; gal-α [1→ 4]gal β
[1→ 4]Glc-ceramide), with exception of Stxe variant that recognizes the globote-
traosylceramide (Gb4; galNAc-β [1→ 3]gal α [1→ 4]gal β [1→ 4]Glc-ceramide).
Several synthetic analogues of Gb3 exists and these are able to distinguish
amongst Stx variants with a modification in the N-acetyl group. Complicat-
ing this picture is the fact that many cellular binding sites to Stx are available,
and each of the subunits in the B pentamer have three Gb3 binding sites [27, 28].
Gb3 is synthesized in the Golgi of eukaryotic cells and is transported to the
plasma membrane, having its trisaccharide residue out-membrane and the non
covalent ceramide hydrocarbon in the plasma membrane. The joining subunit
of Stx specifically recognizes the terminal alpha 1,4 trisaccharide digalactose.
However, not only the part of carbohydrate is important in the toxin joining
mechanism, also the lipid tail is important in the interaction of this toxin with
its receptor. The sensitivity of the cell to the toxin and the linking procedure
between the toxin and the cell can be regulated by many factors. For instance,
changes in the transduction signals can be important for such regulations: an
incubation prolonged with AMPc, or the exposition to butyric acid can induce
the production of new receptors for the Shiga toxin. Cytokines (IL-1), tumoral
necrosis factor (TNF) induced by Shiga toxin or LPS during the infection time
could induce Gb3 synthesis in many types of cells. The induction of Gb3 pro-
duction triggers the action of Shiga toxins and causes severe complication during
the infection. The internalization involves formation of a clathrin-coated pit on
the cell membrane. In some cells, vesicles-bound toxins are subjected to the
fusion with the cellular lysosome, resulting in toxin degradation. In those cells
Stx-sensitives, the endosomal vesicle contain a toxin-complex receptor which is
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transported to the endoplasmatic reticule.
During this process the subunit A is cleaved by a protease of membrane furin-
like, generating a catalytically active 27 kD A1 N-terminal fragment, and a 4 kD
A2 C-terminal fragment which remains attached by a disulphide bound. The
active catalytically fragment for this dimer exerts its effect upon the ribosomes
when is released in the cytoplasm [17, 16, 29].
Toxin can exerts its effect in eukaryotic cells by one of following three mech-
anisms: firstly, the ribosomes inactivation and the inhibition of synthesis of
the cytoplasmic protein causing the cellular death. Secondly, the depurination
in the ribosomes generates a unique response of signals translation named “ri-
botoxic stress response ” (RSR), that leads to the production of cytokines, or
others factors that resulting in many different events including the apoptosis
of the cells implicated. In the last site, the joint of the holotoxin Stx or its
subunit at the receptor, can start a cascade of cytoplasmic signals translation
different of the response RSR. The end result of this events is the cellular death
(apoptosis or necrosis) or an response of inflammation in the cells that remain
viable, and maybe others immediate responses [22].
3 Detection
3.1 Biological Methods
It is considered that an appropriate response to bacterial outbreaks consist in its
early detection and the use of adequate antibiotics to control them. The meth-
ods used to detect food pathogens have been grouped in four mainly categories.
In the first group are the conventional microbiological methods, in which the
food is mixed with selective medium enriched to increase the population of a
target organism. Also, in this categories is located the agar plating in selective
or differential media to isolate the pure culture, and the test of the culture by
means of phenotype analysis or take of metabolic fingerprinting. These con-
ventional microbiological methods, which are considered the gold standard, are
reliable and accurate, but require much time and are very labor intensive to
obtain the results [30]. Typically, the traditional methods involve a series of
steps: pre-enrichment, selective enrichment, biochemical screening and serologi-
cal confirmation. These step are laborious, requiring significant amount of time,
expensive equipment and trained personal [19].
The detection of microorganisms which produce Stx has been difficult, due
to the microorganism diversity and the detection limits of the samples in the
environment [10]. The bacterial detection methods have to be rapid and very
sensitive because, as explained before, the presence of even a single pathogenic
organism in the body or food may become infectious. Extremely selective detec-
tion methodology is required, due to the big numbers of non-pathogenic organ-
isms, which are often present in a complex biological environment, and coexist
with the pathogenic bacterias. The traditional methods used for bacterial iden-
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tification comprises the counting of cells with the aid of a optical microscope or
by flow cytometry; measuring physical parameters by piezocrystals, impedime-
try, redox reactions, optical methods, calorimetry, ultrasound techniques and
detecting cellular compounds such as ATP, DNA, protein, lipid derivatives and
radioactive isotopes [31].
The second group is composed by variants of the polymerase chain reac-
tion (PCR) technique. Numerous articles has been published employing these
methods in the determination of pathogens amongst them, E.coli in food . The
methods to detect and identified the verotoxin produced by E.coli, based in
these PCR genetic techniques, have been developed very recently. An advan-
tage of this techniques is that with small amounts of samples make possible the
accurate detection of the target species [32]. The PCR technique is very sensi-
ble for this task, but require hours to process the sample. Besides considerable
bio-molecular skills are needed to prove the identification. The whole process
could take from 48 hours to five days to obtain results, to this time is needed to
sum the time expended in sample transportation, from the controlled site to the
lab [33]. Moreover, the presence of certain genes has not, necessarily, a direct
correlation with dangerous toxin levels [19].
The PCR in real time is the most used to the quantification of specific frag-
ments of DNA. The amount of product synthesized during PCR is measured
in real time by the detection of a fluorescent signal produced to result of a
specific amplification. This methods is rapid and sensitive, but in some cases
false positive and negative results are obtained, requiring an additional con-
firmation through to the hybridization probe and polymorphism of length of
restriction fragment [30]. Several methods based in real-time PCR have been
commercialized for Shiga toxin genes analysis in microbiologic food [34].
The third group includes the methods of immunosorbent assay (ELISA), its
principle is based in the join of an antibody to the target antigen. It is a accurate
and precise method, ideal for the quantitative and qualitative detection of many
types of protein in complex matrices, when searching objectives are known. The
sensitivity is low and up to 3 or 4 hours are is necessary in order to complete
the analysis [30]. The ELISA for Stx1 and Stx2 can be used in stool sample.
There are also commercial immunoassay for the detection of the Shiga-like toxin
in milk and chopped meat [35, 36].
One of detection methods based in the capture of these toxins with antibodies
was realized by Hattum et al . The presence of verotoxin in the sample is verified
through a fluorescence signal coming from an antibody-antibiotin complex. The
method is complementary to genetic methods, because it allow the detection of
mRNA but does not provides information about if the toxin is only expressed
or it is functional [19].
The researcher Ashkenazi et al , have evaluated the efficacy of a Gb3-based
ELISA for detection of Shiga toxin, both from culture pure plates and, most
importantly, directly from a mixed bacterial culture[37]. The glycodendrimers
and glycol-conjugated nanoparticles has been used as anti-adhesive molecules for
toxins and biosensors to monitor the protein-carbohydrate interactions. The gly-
conanoparticles show the best potential for studying these protein-carbohydrate
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interactions. The size distribution of these nanoparticles is reasonably narrow
and is comparable with the size of the studied biomolecules, moreover, these
structure have been well described and are easily manipulated chemical struc-
tures. The glycopolydiacetylene nanoparticle (GPDA) has been used to moni-
tor receptor-ligand events junctions for viruses, toxins, bacteria and antibody-
receptor interactions, due to its unique colorimetric transition when joining to
these macromolecules. Therefore, due to the well-known affinity of Shiga toxin
towards the final [gal-α1,4-gal] disaccharide unit, GPDA nanoparticles contain-
ing this specific disaccharide sequence, has been used to identify E.coli Shiga
toxin in in 96-well plates [21].
The fourth, and most recent group of detection methodologies is based on
microarray techniques. These methods allow the simultaneous identification, in
foods, of a large number of pathogens with a simple reaction. The basic idea is
that many complementary probes are joined in a matrix shape on a solid surface,
each one of these site contains several copies of specific probes. The matrix is
hybridized with the DNA isolated from the sample of interest, producing a
characteristic fluorescence. During this step of hybridization, the fragment is
joined to the probe about the bases of DNA complementarity. However, this
regular microarrays method needs an expensive equipment, both for exploring
that matrix and for compiling the generated data [30].
3.2 Detection by Biosensors
Many of the reported methods for the detection of pathogenic bacteria are ap-
plied to Escherichia coli. Most E.coli -specific methods have a detection limit
between 103 and 105 cells/mL and some rely on the amplification of specific
genes of the E. coli genome for specific identification [38]. Structure-based,
designed synthetic biosensors have been recently considered as attractive al-
ternative to conventional platforms for pathogens detection. Moreover, these
biosensors have important characteristics, such as high grade of sensitivity and
detection specificity, minimum effort in sample preparation, profitability, minia-
turization and portability to real-time monitoring while reduce the total time
requested for detection. Therefore, a great effort has been allocated the develop-
ment of these fast biosensors of diverse nature, as they are considered promising
devices for pathogenic bacteria detection [39].
Ideal attributes of any element of recognition would be a great stability,
facility of immobilization in the sensor platform and the specificity of recognition
to the host with minimal cross-reactivity to other pathogens agents [40]. In the
detection of biochemical and physiological processes, the biosensors have been
converted in a fundamental tool.
According to the methods used for signal transduction, biosensors are divided
in four groups: mass, optical, electrochemical, and thermal sensors. taking into
account the way used for target identification, biosensors can be classified into
two categories: sensors for direct detection and sensors with indirect detection.
Direct detection biosensors are designed in such a way that the bio-specific
reaction is directly determined in real time by measuring the physical changes
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induced by the complex formation. Whereas indirect detection biosensors are
those in which a preliminary biochemical reaction takes place and then, one of
some products of this reaction are detected by a sensor.
Very often, they have been grouped into the following categories: biosen-
sors based on direct detection of bacteria, flow-injection biosensors, monitoring
bacterial metabolism, detection of enzyme labels, genosensors and the emerg-
ing artifical nose [31]. The mot popular bio-probes employed for these surface
biosensors for pathogens detection are nucleic acid, antibody, entire phages,
phage display peptide (PDP) and more recently the phage’s receptor binding
proteins. Biosensors does not suffer for a long time of sample pre-enrichment,
nor a step of secondary enrichment, therefore, they can predict the level and
type of contamination of food. All this, faster than biological, microbiological,
immunological and conventional molecular methods [40].
For long time nucleic acid lateral flow immunoassays (NALFIA) has been
used as biosensors for the detection of nucleic acid. In these assays, nucleic
acids can be captured on the lateral flow test strips by means of relation of
independent or dependent antibodies. Amongst the advantages of lateral flow
strips can be mentioned: one-step, simplicity, fast results, low cost, versatile
and a prolonged shelf life. Moreover if compared with traditional electrophore-
sis detection, NALFIA has other advantages like shorter response time, and
no needs hazardous reagents. NALFIA can be used as biosensor for bacterial
detection due to its characteristics: test finished after 5 -10 min, species selec-
tivity, direct measurement, portable and designed for field application. This
is complemented with a simple manufacturing process. Finally, if NALFIA
strips are used with coloured nanoparticles, an easy visual detection can be
afforded. This combination overcomes the need of have expensive equipments
which is a major shortcomings in the application of immunosensor techniques,
a fact acknowledged by Noguera et al, whom have reported the use of a carbon
nanoparticles-NALFIAs combination for rapid detection and identification of
genes encoding various STEC virulence factors (vt1, vt2) [38].
The technique of Localized Surface Plasmon Resonance (LSPR) which is
based in the analyzing intermolecular interactions of biomacromolecules have
been used for detection of biological toxins. In the recently study developed by
Nagatsuka et al, was used a portable LSPR detection system that uses glyco-
chips containing Au nanoparticles coated with synthetic oligosaccharides that
specifically bind toxins. The ricin, Shiga toxin, and cholera toxin were selected
as the targets in this study. For every case, the LSPR detection was completed
within 20 min and was highly specific to the target toxin. Because of its sensi-
tivity, a LSPR system based on glyco-nanotechnology is competitive with other
techniques and has the added advantage of being portable and of providing
simple and rapid analysis in contaminated areas [41].
In an assay of rapid detection, efficient, accurate and of low cost, Bai et al,
have developed methods to detect pathogens transmitted by food in the surface
of and optical biosensor thin film. An advantage of this technology is that, due
to the characteristic optic of the thin film to the biosensors chip, the experimen-
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tal results can be visualized by the human eyes without specific instruments.
Therefore, this technology avoids an initial investment on expensive instruments
and can distribute to any laboratory of individual research with basic facilities
for molecular biology. Generally, these methods are rapids and robust, has an
excellent sensitivity and specificity, and are quite competitive, in terms of cost,
when compared with existing technologies [30].
Tu et al in 2006, have developed a biosensor based on the immobilization of
an antibody on a optic fiber for fast detection of low levels of E.coli O157: H7
and to Shiga-similar toxins in ground beef sample. The principle of the sensor is
an type sandwich immunoassay using an antibody specific to E.coli O157: H7
or its toxins. A polyclonal antibody was first immobilized on polystyrene fiber
waves guides through a reaction of biotin-streptavidin, which served as entity
for capturing bacterias and toxins. The fluorescent molecules immobilized on
the fiber were excited by the evanescent wave, and the portion of the emission
light was transmitted by the fiber and finally collected in the photo-detector at
670-710 nm [42].
Another similar approach was used by Ngundi et al in 2006, which have stud-
ied an array-based technique that provides the capability to perform multiple
analysis simultaneously. They report a technique for immobilizing sugars onto
planar waveguides and employing the patterned arrays to analyze carbohydrate-
binding protein toxins. In this study are used an array biosensor, and are
employing two monosaccharide-derivatives: N-acetylneuraminic acid (Neu5Ac),
and N-acetyl galactosamine (GalNAc) as receptors for protein toxins [43].
4 Conclusion
Large outbreaks of human illness with severe manifestations due to STEC in-
fections have occurred in recent decades caused by Shiga toxin producers mi-
croorganisms. The high infectious capacity of these microorganism make dan-
gerous even the presence of few individuals in a given medium, as a results these
episodes has received great attention by the community scientific.
These outbreaks have taken place due to an historical little monitoring or
surveillance in the food supply chain. This incomplete control on food or its
precursors is attributable, in part, to the lack of standardized methods for the
detection or enumeration of these bacteria in food matrices, but they are also
due to the lack of consensus on which serotypes are most important. Still, other
issues difficult the battle against pathogens, such as: the rapid urbanization,
the increasing number of poor and hungry people around the world, the rapid
development of transportation, environmental change and the human activity.
The war between humans and pathogens never ends. New diseases are con-
tinuously appearing, and these organism will find more chances to interact with
humans. Therefore, we must take advantage of new advances in technology and
the strengthen the search to develop new diagnostic mechanisms and design new
drugs to fight against infectious diseases.
In this scenario, it is a challenge to create techniques to detect the bacterias
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involved in these outbreaks with high degree of efficiency. In recent times, the
use of structure-based designed biosensors have emerged as an alternative, with
the necessary properties for reliable and effective use in routine applications.
Many researchers are in the search of biosensor systems with specificity to dis-
tinguish the target bacteria in a multi-organism matrix, the sensitivity to detect
bacteria directly, the adaptability to detect different analytes without sample
pre-enrichment and the capacity to give real-time results. At the same time,
the biosensor must have relatively simple and inexpensive configurations. In the
case of STx, little have been done in this field, no robust sensors for continuous
water and food monitoring have been developed. Therefore, the necessity to
explore new ways to develop robust, long-time of use sensors, exists, and its a
challenge to be accomplished in the next years
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